NFKB1 and cancer: NF-κB activation or phosphorylation can transactivate cyclooxygenase-2 or allograft inflammatory factor-1 expressed in inflammatory or malignant tumors, and NF-κB can activate multiple inflammatory factors, such as TNF-α, IL-6, IL-8, and matrix metallopeptidase-9 [26].